Journals / Turkish Journal of Urology / 2017 / Cilt: 43 - Sayı: 2

22-year survival following radical nephrectomy and several metastasectomies in a case of renal cell carcinoma

Radikal nefrektomi ve çoklu metastazektomiler sonrası 22 yıl sağkalım sağlanan böbrek karsinomu vakası

Pages
216–219
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As far as we know, this case is the first patientwith the longest survival whose non-pulmonary metastases had been treated with more than one surgicalinterventions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Renal cell carcinoma (RCC) is a common malignancy.
📊
Key Findings & Data:At the time of diagnosis, 23% of the patients havemetastatic disease. and 25% of patients will develop metastasis during follow-up period after nephrectomy.Nearly 80% of them develop within the first 5 years.
💡
Conclusion & Impact:As far as we know, this case is the first patientwith the longest survival whose non-pulmonary metastases had been treated with more than one surgicalinterventions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Renal cell carcinoma (RCC) is a common malignancy. Metastases can be seen both synchronously, at thetime of diagnosis, and metachronously during follow-up. At the time of diagnosis, 23% of the patients havemetastatic disease. and 25% of patients will develop metastasis during follow-up period after nephrectomy.Nearly 80% of them develop within the first 5 years. However late metastasis of RCC have been alsoreported within the postoperative 10 years in the literature. For metastatic lesions, if surgically feasible,metastasectomy, and targeted pharmaceutical agents have been recommended. However any randomizedcontrolled study which aimed to determine treatment protocol in patients who develop multiple metastaseshas not been cited in the literature. Herein, we are presenting a case with renal cell carcinoma in whomwithin 22 years of follow-up after 10 years of survival multiple metastases in different organs were detectedwhich were managed with surgical, and medical treatments. As far as we know, this case is the first patientwith the longest survival whose non-pulmonary metastases had been treated with more than one surgicalinterventions.

Özet

Böbrek hücreli karsinom, sık görülen bir kanserdir. Gerek tanı anında (senkron) gerekse takip sırasında (metakron) metastaz görülebilir. Tanı anında hastaların yaklaşık %23'ü metastatik hastalığa sahiptir, takip sırasında da %25 hastada metastaz gelişmesi beklenir. Bunların yaklaşık %80’i ilk 5 yılda gelişse de, on yıl sonrasında da bildirilen geç metastazlar vardır. Metastatik lezyonlar için, cerrahi açıdan mümkün olduğu sürece metastazektomi ve hedefe yönelik ajanlar önerilmektedir, ancak izlem sırasında saptanan çoklu metastazda tedavi protokolünü belirlemek için randomize kontrollü bir çalışma literatürde bulunmamaktadır. Yirmi iki yıllık takip süresince 10 yıllık hastalıksız sağkalım sonrası, farklı organlarda saptanan çoklu metastazları cerrahi ve medikal yöntemlerle tedavi edilen bu vaka, bildiğimiz kadarı ile akciğer dışı metastazları, birden çok cerrahi ile tedavi edilen, en uzun sağkalımlı hastadır

🔖

Cite This Article

BAŞARAN, M., ARAS, N., TUNÇ, H. M., YÜCEL, Ö. B. (2022). 22-year survival following radical nephrectomy and several metastasectomies in a case of renal cell carcinoma. Turkish Journal of Urology, Cilt: 43 - Sayı: 2, 216–219. https://ajindex.com/articles/614421

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998;16:2261-6.[CrossRef] Alt AL, Boorjian SA, Lohse CM, Costello BA, Leibovich BC, Blute ML. Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 2011;117:2873-82. [CrossRef] Kierney PC, van Heerden JA, Segura JW, Weaver AL. Surgeon’s role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review. Ann Surg Oncol 1994;1:345-52. [CrossRef] Russo P. Multi-modal treatment for metastatic renal cancer: the role of surgery. World J Urol 2010;28:295-301. [CrossRef] Staehler MD, Kruse J, Haseke N, Stadler T, Roosen A, Karl A, et al. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 2010;28:543-7. [CrossRef] Ramírez-Plaza CP, Domínguez-López ME, Blanco-Reina F. Thyroid metastasis as initial presentation of clear cell renal carcinoma. Int J Surg Case Rep 2015;10:101-3. [CrossRef] Moletta L, Milanetto AC, Vincenzi V, Alaggio R, Pedrazzoli S, Pasquali C. Pancreatic secondary lesions from renal cell carcinoma. World J Surg 2014;38:3002-6. [CrossRef] Ballarin R, Spaggiari M, Cautero N, De Ruvo N, Montalti R, Longo C, et al. Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol 2011;17:4747-56. [CrossRef] Adsay NV, Andea A, Basturk O, Kilinc N, Nassar H, Cheng JD. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Arch 2004;444:527-35. [CrossRef] Jost G, Zimmerer S, Frank S, Cordier D, Merlo A. Intradural spinal metastasis of renal cell cancer. Report of a case and review of 26 published cases. Acta Neurochir (Wien) 2009;151:815-21. [CrossRef] Kato S, Murakami H, Takeuchi A, Demura S, Yoshioka K, Kawahara N, et al. Fifteen-year survivor of renal cell carcinoma after metastasectomies for multiple bone metastases. Orthopedics 2013;36:e1454-7. Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, et al. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am 2007;89:1794-801. [CrossRef] Kollender Y, Bickels J, Price WM, Kellar KL, Chen J, Merimsky O, et al. Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention. J Urol 2000;164:1